Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Oncostatin M Is a Novel Niche Factor That Restrains Hematopoietic Stem Cell Mobilization in Response to G-CSF and CXCR4 Antagonist Plerixafor

Kavita Bisht, PhD, Crystal McGirr, Kylie A Alexander, Whitney Fleming, Natalie Sims, Gerhard Müller- Newen, Ingrid G Winkler, PhD, Jean-Pierre Levesque, PhD

Blood (2019) 134 (Supplement_1): 4469.

https://doi.org/10.1182/blood-2019-127431

Published: 2019

Journal Articles

Macrophage Involvement in the Response of Acute Myeloid Leukaemia to Chemotherapy

Thomas Keech, BSc, Crystal McGirr, Ingrid G Winkler, PhD, Jean-Pierre Levesque, PhD

Blood (2017) 130 (Supplement 1): 5069.

https://doi.org/10.1182/blood.V130.Suppl_1.5069.5069

Published: 2017

Journal Articles

Suppression of Medullar Erythropoiesis in Response to Bacterial Lipopolysaccharides (LPS) Involves Two Distinct TLR4-Dependent Mechanisms with Contrasted Requirements for G-CSF Receptors

Kavita Bisht, PhD, Rebecca Jacobsen, BSc, Bianca Nowlan, Crystal McGirr, Marion Brunck, Thomas Keech, Ingrid G Winkler, PhD, Jean-Pierre Levesque, PhD

Blood (2016) 128 (22): 546.

https://doi.org/10.1182/blood.V128.22.546.546

Published: 2016

Journal Articles

Interaction of c-Myb with p300 is required for the induction of acute myeloid leukemia (AML) by human AML oncogenes

Diwakar R. Pattabiraman, Crystal McGirr, Konstantin Shakhbazov, Valerie Barbier, Keerthana Krishnan, Pamela Mukhopadhyay, Paula Hawthorne, Ann Trezise, Jianmin Ding, Sean M. Grimmond, Peter Papathanasiou, Warren S. Alexander, Andrew C. Perkins, Jean-Pierre Levesque, Ingrid G. Winkler, Thomas J. Gonda

Blood (2014) 123 (17): 2682–2690.

https://doi.org/10.1182/blood-2012-02-413187

Published: 2014

Includes: Supplemental data

Journal Articles

Interaction of c-Myb with p300 Is Required for the Induction of Acute Myeloid Leukemia by Human AML Oncogenes, and Represents a Potential Therapeutic Target.

Diwakar R Pattabiraman, PhD, Konstantin Shakhbazov, PhD, Valerie Barbier, Crystal McGirr, BSc (Hons), Keerthana Krishnan, BSc (Hons), Pamela Mukhopadhyay, PhD, Paula Hawthorne, PhD, Ann Trezise, PhD, Sean Grimmond, PhD, Peter Papathanasiou, Andrew C. Perkins, MBBS, PhD, FRACP, FRCPA, Jean-Pierre Levesque, PhD, Warren S. Alexander, Ingrid G Winkler, PhD, Thomas J Gonda, PhD

Blood (2012) 120 (21): 2402.

https://doi.org/10.1182/blood.V120.21.2402.2402

Published: 2012

NARROW

Oncostatin M Is a Novel Niche Factor That Restrains Hematopoietic Stem Cell Mobilization in Response to G-CSF and CXCR4 Antagonist Plerixafor

Macrophage Involvement in the Response of Acute Myeloid Leukaemia to Chemotherapy

Suppression of Medullar Erythropoiesis in Response to Bacterial Lipopolysaccharides (LPS) Involves Two Distinct TLR4-Dependent Mechanisms with Contrasted Requirements for G-CSF Receptors

Interaction of c-Myb with p300 is required for the induction of acute myeloid leukemia (AML) by human AML oncogenes

Interaction of c-Myb with p300 Is Required for the Induction of Acute Myeloid Leukemia by Human AML Oncogenes, and Represents a Potential Therapeutic Target.

Email alerts

ASH Publications

American Society of Hematology

Oncostatin M Is a Novel Niche Factor That Restrains Hematopoietic Stem Cell Mobilization in Response to G-CSF and CXCR4 Antagonist Plerixafor

Macrophage Involvement in the Response of Acute Myeloid Leukaemia to Chemotherapy

Suppression of Medullar Erythropoiesis in Response to Bacterial Lipopolysaccharides (LPS) Involves Two Distinct TLR4-Dependent Mechanisms with Contrasted Requirements for G-CSF Receptors

Interaction of c-Myb with p300 is required for the induction of acute myeloid leukemia (AML) by human AML oncogenes

Interaction of c-Myb with p300 Is Required for the Induction of Acute Myeloid Leukemia by Human AML Oncogenes, and Represents a Potential Therapeutic Target.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only